SeaStar Medical Holding Corp (ICUCW) stock

ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value

$0.01−0.01 (-34.73%)

Close on Oct 30, 2026Market cap $9.87MP/E –Yield –

SeaStar Medical statistics

76 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Nov 12, 2026 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Oct 30, 2026

Valuation ratiosIndustry

Market Cap: $9.87M; $470.91M
Enterprise Value: $2.91M; $446.92M
PS Ratio: 5.76; 3.08
PB Ratio: 2.30; 3.08
P/TBV Ratio: 2.30; 4.37

Enterprise valuationIndustry

EV / Sales: 1.70; 2.88

Share statisticsIndustry

Shares Outstanding: 4M; 44M
Shares Change (YoY): 393.1%; 3.50%
Shares Change (QoQ): 6.66%; 0.31%
Float: 4M; 37M
Shares Held by Insiders: 6.54%; 9.82%
Shares Held by Institutions: 28.1%; 59.9%

Short sellingIndustry

Short Interest: 143,724; –
Short Interest Change: 18.1%; 0.63%
Days to Cover: 3.16; 3.83

Stock price statisticsIndustry

52-Week High: $6.00; –
52-Week Low: $2.07; –
20-Day Moving Average: $3.03; –
50-Day Moving Average: $3.20; –
200-Day Moving Average: $3.33; –
Average True Range (14): $0.32; –
Price Change (1 Week): -7.05%; -1.11%
Price Change (1 Month): -40.3%; -4.57%
Price Change (3 Months): -29.9%; -7.22%
Price Change (6 Months): -48.7%; -5.63%
Price Change (YTD): -6.67%; -4.10%
Price Change (1 Year): -60.7%; -6.46%
Price Change (3 Years): -98.9%; 8.09%
Price Change (5 Years): -99.9%; -48.0%
Average Volume (10 Days): 132,766; –
Average Volume (20 Days): 249,873; –
Average Volume (90 Days): 116,661; –
Relative Volume: 0.70; 0.89
Relative Strength Index (14): 35.4; 44.9
Volatility (1 Year): 111.9%; 64.2%
Beta (5 Years): 0.86; 1.06

MarginsIndustry

Gross Margin: 92.6%; 55.4%
Operating Margin: -816.6%; -5.39%
Pretax Margin: -795.3%; -2.95%
Profit Margin: -795.5%; -10.3%
EBITDA Margin: -816.6%; -2.67%

Returns on capitalIndustry

Return on Equity (ROE): -356.9%; -18.2%
Return on Assets (ROA): -160.0%; -13.0%
Return on Capital Employed (ROCE): -325.6%; -9.07%

Financial positionIndustry

Current Ratio: 1.89; 2.49
Quick Ratio: 1.65; 1.53
Interest Coverage: -518.11; -1.85

GrowthIndustry

Revenue Growth (YoY): 123.6%; 9.06%

EfficiencyIndustry

Asset Turnover: 0.20; 0.58
Inventory Turnover: 1.64; 2.22
Revenue Per Employee: $100.77K; $324.29K
Profits Per Employee: -$801.59K; -$51.88K
Employee Count: 17; 185
WACC: 9.26%; 9.89%

Income statement (TTM)Industry

Revenue: $1.71M; $102.39M
Gross Profit: $1.59M; $61.99M
Operating Income: -$13.99M; -$4.31M
Pretax Income: -$13.62M; -$2.37M
Net Income: -$13.63M; -$6.57M
EBITDA: -$13.99M; -$1.98M
EPS (Diluted): -$3.93; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $6.96M; $36.66M
Net Cash (Debt): $6.96M; $3.92M
Net Cash Per Share: $1.58; $0.28
Equity (Book Value): $4.30M; $55.33M
Book Value Per Share: $0.97; $2.90
Tangible Book Value: $4.30M; $10.79M
Working Capital: $3.88M; $56.72M

Cash flow (TTM)Industry

Operating Cash Flow: -$13.69M; -$566.22K

Dividends and yieldsIndustry

Earnings Yield: -138.0%; -5.33%
Buyback Yield: -122.7%; 0.79%
Shareholder Yield: -122.7%; 0.88%

Taxes and interestIndustry

Interest Expense: $27.00K; $5.22M
Income Tax: $3.00K; $1.58M

Scores and fair valueIndustry

Altman Z-Score: -28.97; 2.40
Piotroski F-Score: 5; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

Period	ICUCW	S&P 500	Difference	ICUCW per year	S&P 500 per year
1 month	-33.1%	-0.9%	−32.2 pts
3 months	-43.5%	+2.1%	−45.7 pts
Year to date	-3.5%	+11.7%	−15.2 pts
1 year	-71.3%	+12.4%	−83.7 pts
3 years	-78.1%	+88.6%	−166.7 pts	-39.7%	+23.5%
5 years	-97.9%	+75.9%	−173.8 pts	-53.8%	+12.0%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.

0M ICUCW shares were sold short on Oct 15, 2026, down 50.7% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 50.8% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 15, 2026	1,834	-50.7%	24,994	1.0
Sep 30, 2026	3,721	-44.7%	3,588	1.0
Sep 15, 2026	6,726	-24.2%	17,730	1.0
Aug 31, 2026	8,873	+1.5%	16,169	1.0
Aug 14, 2026	8,739	-22.2%	8,171	1.1
Jul 31, 2026	11,226	-16.2%	3,833	2.9
Jul 15, 2026	13,391	-33.4%	58,364	1.0
Jun 30, 2026	20,121	+63.1%	18,234	1.1
Jun 15, 2026	12,333	-76.8%	307,867	1.0
May 29, 2026	53,243	+6.0%	9,801	5.4
May 15, 2026	50,223	+96.4%	93,047	1.0
Apr 30, 2026	25,571	+78.6%	59,992	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in SeaStar Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jan 5, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ICUCW.

Compare: ICUCW vs RNXT · ICUCW vs OSRH · ICUCW vs HRGN · ICUCW vs PLSE · ICUCW vs AURX

Revenue growth123.6% · median 44.6%

Gross margin92.6% · median 35.3%

Operating margin-816.6% · median -685.2%

Net margin-795.5% · median -651.1%

Company	Revenue	Growth
AURX	$5.20M	+166.6%
RNXT	$1.98M	–
OSRH	$1.81M	-50.2%
ICUCW	$1.71M	+123.6%
PLSE	$1.19M	–
HRGN	$982.00K	+44.6%

Company

Next earnings (est.): Nov 12, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 17
Auditor: WithumSmith+Brown, PC
SEC CIK: 1831868

Advertisement
300 × 250